Year: 2023

Ligand will receive 13% of all soticlestat royalties and milestone payments owed to Ovid Ovid secures a $30 million non-dilutive capital infusion from Ligand, which Ovid expects to extend its cash runway into 2026 while simultaneously retaining 87% of the interest in soticlestat Transaction provides further validation of soticlestat as a potential treatment for Lennox-Gastaut syndrome and Dravet syndromeNEW YORK and SAN DIEGO, Oct. 18, 2023 (GLOBE NEWSWIRE) — Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company dedicated to developing medicines that transform the lives of people with rare epilepsies and seizure-related disorders, and Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that Ligand has acquired a 13 percent portion of the royalties and milestones owed to Ovid related to the potential...

System utilizes predictive algorithms integrated into proprietary cloud platform to manage thousands of solar installations automaticallyTurbo Energy’s Energy Storage SolutionTurbo Energy’s Energy Storage SolutionTurbo Energy’s Energy Storage Solution Valencia, Spain, Oct. 18, 2023 (GLOBE NEWSWIRE) — Turbo Energy, S.A. (Nasdaq: TURB), a Spain-based company specializing in photovoltaic solar energy storage, today announced another success after obtaining the patent, granted for Spain, for one of its software developments that allows it to position its product, SUNBOX, among the most innovative residential photovoltaic equipment on the market. Turbo Energy believes that this solution marks a milestone in the electric power industry by offering a comprehensive smart management experience for home photovoltaic...

Results from the RESPONSE registrational study to be highlighted in oral presentation on Monday, November 13th Fifth oral late-breaking presentation of seladelpar results at The Liver Meeting® NEWARK, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic diseases, today announced that a late-breaking presentation highlighting results from the RESPONSE Phase 3 study of seladelpar in patients with primary biliary cholangitis (PBC) will be presented at The Liver Meeting® of the American Association for the Study of Liver Diseases (AASLD), in Boston, MA (November 10th – 14th). Seladelpar is a potent, selective, orally active delpar or PPARδ agonist, in development for the treatment of adult patients with...

Members of AON’s leadership team will speak and moderate several panel sessions at the Summit.AON Leaders Selected to Speak at AVBCC 2023 Summit.From left to right: Stephen “Fred” Divers, MD; James Gilmore, PharmD; Alti Rahman, MHA, MBA, CSSBB; Susan Sabo-Wagner, MSN, RN, OCNFORT MYERS, Fla., Oct. 18, 2023 (GLOBE NEWSWIRE) — American Oncology Network (AON) (Nasdaq: AONC) is pleased to announce that Stephen “Fred” Divers, MD, chief medical officer; James Gilmore, PharmD, chief pharmacy and clinical services officer; Alti Rahman, MHA, MBA, CSSBB, chief strategy and innovation officer; and Susan Sabo-Wagner, MSN, RN, OCN, vice president of clinical innovation, have been invited to speak at the Association for Value-Based Cancer Care (AVBCC) 2023 Summit. The in-person event is scheduled for October 18 through...

NEW YORK, Oct. 18, 2023 (GLOBE NEWSWIRE) — Aspen Group, Inc. (“AGI”) (OTCQB: ASPU), an education technology holding company, today announced its successful up-listing from the OTC Pink Market to the OTCQB® Venture Market (the “OTCQB”) effective for trading October 18, 2023 at the open. Aspen Group will continue to trade under the ticker symbol “ASPU.” The OTCQB, operated by OTC Markets Group, Inc., is a premier market designed for developing and entrepreneurial companies in the United States and abroad committed to providing investors with improved market visibility to enhance trading liquidity. To be eligible for trading on the OTCQB, companies must be current in their financial reporting with the Securities and Exchange Commission (the “SEC”) or OTC Markets Group, Inc., pass a minimum...

TORONTO, Oct. 18, 2023 (GLOBE NEWSWIRE) — TerrAscend Corp. (“TerrAscend” or the “Company”) (TSX: TSND) (OTCQX: TSNDF), a leading North American cannabis company, today announced that its executive management team will participate in the Jefferies Cannabis Summit being held on October 25, 2023 in New York City. Ziad Ghanem, Chief Executive Officer, will participate in a panel discussion, “Lunch and Learn: Brands Will Ultimately Win and Drive Value”, moderated by Owen Bennett, Global Tobacco and Cannabis Senior Research Analyst, on Wednesday, October 25, 2023 at 12:00 PM ET. Management, including Ziad Ghanem and Keith Stauffer, Chief Financial Officer, will host one-on-one meetings throughout the conference. To schedule a meeting with management, please reach out to your conference representative or email IR@TerrAscend.com. About...

Frank Ingriselli to Assume Role of Vice Chairman BAKERSFIELD, CA, Oct. 18, 2023 (GLOBE NEWSWIRE) — Trio Petroleum Corp (NYSE American: TPET) (“Trio” or the “Company”), a California-based oil and gas company, today announced that Michael L. Peterson has been appointed as the new CEO of Trio effective October 23, 2023, replacing Frank C. Ingriselli who will be resigning, effective as of the same date. Mr. Peterson is currently a member of the Company’s Board of Directors, serving as the Chairman of the Audit Committee and the Compensation Committee, and the Company’s Special Acquisitions Committee. Mr. Ingriselli will assume the role of Vice Chairman of Trio, and enter into a consulting engagement to support the CEO transition to Mr. Peterson through December 2023. Mr. Ingriselli plans to focus a good part of his future on growing...

NORCROSS, Ga., Oct. 18, 2023 (GLOBE NEWSWIRE) — CoreCard Corporation (NYSE: CCRD), the leading provider of innovative credit technology solutions and processing services to the financial technology and services market, intends to hold an investor conference call on November 1, 2023, at 11:00 A.M. Eastern Time in conjunction with the company’s earnings release for the quarter ended September 30, 2023. The company plans to issue a press release with the financial results for the period before the market opens on November 1, 2023. Interested investors are invited to attend the conference call by accessing the webcast at https://www.webcast-eqs.com/register/corecard110123/en or by dialing 1-877-407-0890. As part of the conference call CoreCard will be conducting a question-and-answer session where participants are invited to email...

Expanded Lineup Includes 15 New Shows, Over 1,500 Episodes, and 2,000 Hours of Programming Year to Date PodcastOne Named Top 10 Publisher for September According to Podtrac LOS ANGELES, CA, Oct. 18, 2023 (GLOBE NEWSWIRE) — via NewMediaWire –PodcastOne (NASDAQ: PODC), a leading podcast platform and a subsidiary of LiveOne (NASDAQ: LVO), announced today that it has increased its overall slate of shows to 178 for a total of over 3 million programming hours and nearly 60,000 episodes. PodcastOne has added 15 new shows to the network for a combined 1,500 episodes and over 2,000 hours of available programming year to date. “PodcastOne has had a record year due in no small part to us launching and acquiring several key podcasts. We’ve honed our growth and expanded our line-up of programming to complement top performing podcasts already...